159 related articles for article (PubMed ID: 37939855)
1. Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis.
Ghallab A; González D; Strängberg E; Hofmann U; Myllys M; Hassan R; Hobloss Z; Brackhagen L; Begher-Tibbe B; Duda JC; Drenda C; Kappenberg F; Reinders J; Friebel A; Vucur M; Turajski M; Seddek AL; Abbas T; Abdelmageed N; Morad SAF; Morad W; Hamdy A; Albrecht W; Kittana N; Assali M; Vartak N; van Thriel C; Sous A; Nell P; Villar-Fernandez M; Cadenas C; Genc E; Marchan R; Luedde T; Åkerblad P; Mattsson J; Marschall HU; Hoehme S; Stirnimann G; Schwab M; Boor P; Amann K; Schmitz J; Bräsen JH; Rahnenführer J; Edlund K; Karpen SJ; Simbrunner B; Reiberger T; Mandorfer M; Trauner M; Dawson PA; Lindström E; Hengstler JG
J Hepatol; 2024 Feb; 80(2):268-281. PubMed ID: 37939855
[TBL] [Abstract][Full Text] [Related]
2. A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans.
Caballero-Camino FJ; Rodrigues PM; Wångsell F; Agirre-Lizaso A; Olaizola P; Izquierdo-Sanchez L; Perugorria MJ; Bujanda L; Angelin B; Straniero S; Wallebäck A; Starke I; Gillberg PG; Strängberg E; Bonn B; Mattsson JP; Madsen MR; Hansen HH; Lindström E; Åkerblad P; Banales JM
Hepatology; 2023 Sep; 78(3):709-726. PubMed ID: 36999529
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M
J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078
[TBL] [Abstract][Full Text] [Related]
4. Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice.
Kunst RF; de Waart DR; Wolters F; Duijst S; Vogels EW; Bolt I; Verheij J; Beuers U; Oude Elferink RPJ; van de Graaf SFJ
JHEP Rep; 2022 Nov; 4(11):100573. PubMed ID: 36160754
[TBL] [Abstract][Full Text] [Related]
5. Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice.
Fickert P; Krones E; Pollheimer MJ; Thueringer A; Moustafa T; Silbert D; Halilbasic E; Yang M; Jaeschke H; Stokman G; Wells RG; Eller K; Rosenkranz AR; Eggertsen G; Wagner CA; Langner C; Denk H; Trauner M
Hepatology; 2013 Dec; 58(6):2056-69. PubMed ID: 23813550
[TBL] [Abstract][Full Text] [Related]
6. Regulation of renal tubular bile acid transport in the early phase of an obstructive cholestasis in the rat.
Schlattjan JH; Winter C; Greven J
Nephron Physiol; 2003; 95(3):p49-56. PubMed ID: 14646358
[TBL] [Abstract][Full Text] [Related]
7. Effect of the dimeric bile acid analogue S 0960, a specific inhibitor of the apical sodium-dependent bile salt transporter in the ileum, on the renal handling of taurocholate.
Schlattjan JH; Fehsenfeld H; Greven J
Arzneimittelforschung; 2003; 53(12):837-43. PubMed ID: 14732964
[TBL] [Abstract][Full Text] [Related]
8. Bile acid transporters: structure, function, regulation and pathophysiological implications.
Alrefai WA; Gill RK
Pharm Res; 2007 Oct; 24(10):1803-23. PubMed ID: 17404808
[TBL] [Abstract][Full Text] [Related]
9. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
[TBL] [Abstract][Full Text] [Related]
10. Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis.
Hruz P; Zimmermann C; Gutmann H; Degen L; Beuers U; Terracciano L; Drewe J; Beglinger C
Gut; 2006 Mar; 55(3):395-402. PubMed ID: 16150853
[TBL] [Abstract][Full Text] [Related]
11. NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice.
Krones E; Eller K; Pollheimer MJ; Racedo S; Kirsch AH; Frauscher B; Wahlström A; Ståhlman M; Trauner M; Grahammer F; Huber TB; Wagner K; Rosenkranz AR; Marschall HU; Fickert P
J Hepatol; 2017 Jul; 67(1):110-119. PubMed ID: 28242240
[TBL] [Abstract][Full Text] [Related]
12. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
Meadows V; Marakovits C; Ekser B; Kundu D; Zhou T; Kyritsi K; Pham L; Chen L; Kennedy L; Ceci L; Wu N; Carpino G; Zhang W; Isidan A; Meyer A; Owen T; Gaudio E; Onori P; Alpini G; Francis H
Am J Physiol Gastrointest Liver Physiol; 2023 Jan; 324(1):G60-G77. PubMed ID: 36410025
[TBL] [Abstract][Full Text] [Related]
13. An important intestinal transporter that regulates the enterohepatic circulation of bile acids and cholesterol homeostasis: The apical sodium-dependent bile acid transporter (SLC10A2/ASBT).
Xiao L; Pan G
Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):509-515. PubMed ID: 28336180
[TBL] [Abstract][Full Text] [Related]
14. Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis.
Soroka CJ; Mennone A; Hagey LR; Ballatori N; Boyer JL
Hepatology; 2010 Jan; 51(1):181-90. PubMed ID: 19902485
[TBL] [Abstract][Full Text] [Related]
15. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat.
Lee J; Azzaroli F; Wang L; Soroka CJ; Gigliozzi A; Setchell KD; Kramer W; Boyer JL
Gastroenterology; 2001 Dec; 121(6):1473-84. PubMed ID: 11729126
[TBL] [Abstract][Full Text] [Related]
16. Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis.
Slitt AL; Allen K; Morrone J; Aleksunes LM; Chen C; Maher JM; Manautou JE; Cherrington NJ; Klaassen CD
Biochim Biophys Acta; 2007 Mar; 1768(3):637-47. PubMed ID: 17141734
[TBL] [Abstract][Full Text] [Related]
17. Neither intestinal sequestration of bile acids nor common bile duct ligation modulate the expression and function of the rat ileal bile acid transporter.
Arrese M; Trauner M; Sacchiero RJ; Crossman MW; Shneider BL
Hepatology; 1998 Oct; 28(4):1081-7. PubMed ID: 9755246
[TBL] [Abstract][Full Text] [Related]
18. Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges.
Li M; Wang Q; Li Y; Cao S; Zhang Y; Wang Z; Liu G; Li J; Gu B
Pharmacol Ther; 2020 Aug; 212():107539. PubMed ID: 32201314
[TBL] [Abstract][Full Text] [Related]
19. Cholemic nephropathy - Historical notes and novel perspectives.
Krones E; Pollheimer MJ; Rosenkranz AR; Fickert P
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1356-1366. PubMed ID: 28851656
[TBL] [Abstract][Full Text] [Related]
20. Bile Acids in Cholestasis and its Treatment.
Arab JP; Cabrera D; Arrese M
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s53-s57. PubMed ID: 29080340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
